Arbutus Biopharma

TECH UPDATE: Since we don't serve ads to Premium Members, our "premium" URL is not affected by the new code now required by our ad partners. So, rather than wait for us to resolve all these lovely new code conflicts suddenly plaguing our free, ad-supported "www" pages (a process which will likely take days), Premium Members can enjoy full site functionality now by simply logging in to their premium accounts at https://premium.investorvillage.com If you need password assistance, don't hesitate to contact us. That's what we're here for.

ABUS / Message Board / Read Message

BOARD

GROUPS

Keyword
Subject

Between			and
Rec'd By

Authored By
Minimum Recs

return to message board, top of board

Msg 34638 of 34692 at 6/17/2019 9:27:15 AM by

In response to msg 34637 by Steve_382	view thread

Re: New President & CEO at Arbutus Bio

Viiv healthcare (where Mr. Collier served as president): 76.5% of the company is now owned by GlaxoSmithKline, 13.5% by Pfizer and 10% by Shionogi. Has a significant market share of the HIV market.

e-mail to a friend

printer-friendly

add to library

| More

Recs: 2 Views: 193

return to message board, top of board

view thread Replies
Msg #	Subject	Author	Recs	Date Posted
34639	Re: New President & CEO at Arbutus Bio	The Rooster	0	6/17/2019 10:30:22 AM


	About Us • Contact Us • Follow Us on Twitter • Members Directory • Help Center • Advertise Not a member yet? What are you waiting for? Create Account Want to contribute? Support InvestorVillage by donating © 2003-2018 Investorvillage.com. All rights reserved. User Agreement